Murine Abortion is Associated with Enhanced Hyaluronan Expression and Abnormal Localization at the Fetomaternal Interface

Placenta

Volumn 30, Issue 1, 2009, Pages 88-95

  Cordo Russo, R ^a,b   Garcia, M G ^a,b   Barrientos, G ^a   Orsal, A S ^a   Viola, M ^c   Moschansky, P ^a   Ringel, F ^a   Passi, A ^c   Alaniz, L ^d   Hajos, S ^b   Blois, S M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

Hyaluronan; Hyaluronan molecular size; Hyaluronan synthases; Hyaluronidases; Murine pregnancy

Indexed keywords

HYALURONAN SYNTHASE; HYALURONIC ACID; HYALURONIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MOUSE; NIDATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ANIMALS; DECIDUA; EMBRYO IMPLANTATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, INBRED DBA; PREGNANCY; RNA, MESSENGER; TROPHOBLASTS;

EID: 57849094463     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.10.013     Document Type: Article

References (44)

1. Duc-Goiran P., Mignot T.M., Bourgeois C., and Ferre F. Embryo-maternal interactions at the implantation site: a delicate equilibrium. Eur J Obstet Gynecol Reprod Biol 83 1 (1999) 85-100
2. Wang H., and Dey S.K. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 7 3 (2006) 185-199
3. Malassiné A., Frendo J.L., and Evain-Brion D. A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update 9 6 (2003) 531-539
4. Sharkey A.M., and Smith S.K. The endometrium as a cause of implantation failure. Best Pract Res Clin Obstet Gynaecol 17 2 (2003) 289-307
5. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200 4 (2003) 448-464
6. Toole B.P. Hyaluronan in morphogenesis. Semin Cell Dev Biol 12 2 (2001) 79-87
7. Weigel P.H., and DeAngelis P.L. Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem 282 51 (2007) 36777-36781
8. Csoka A.B., Frost G.I., and Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 20 8 (2001) 499-508
9. Paiva P., Van Damme M.P., Tellbach M., Jones R.L., Jobling T., and Salamonsen L.A. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol 98 2 (2005) 193-202
10. Jiang D., Liang J., and Noble P.W. Hyaluronan in tissue injery and repair. Annu Rev Cell Dev Biol 23 (2007) 435-461
11. Mummert M.E. Immunologic roles of hyaluronan. Immunol Res 31 3 (2005) 189-206
12. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4 7 (2004) 528-539
13. Turley E.A., Noble P.W., and Bourguignon L.Y. Signaling properties of hyaluronan receptors. J Biol Chem 277 7 (2002) 4589-4592
14. Deed R., Rooney P., Kumar P., Norton J.D., Smith J., Freemont A.J., et al. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J Cancer 71 2 (1997) 251-256
15. Termeer C.C., Hennies J., Voith U., Ahrens T., Weiss J.M., Prehm P., et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165 4 (2000) 1863-1870
16. Carson D.D., Dutt A., and Tang J.P. Glycoconjugate synthesis during early pregnancy: hyaluronate synthesis and function. Dev Biol 120 1 (1987) 228-235
17. Brown J.J., and Papaioannou V.E. Distribution of hyaluronan in the mouse endometrium during the periimplantation period of pregnancy. Differentiation 52 1 (1992) 61-68
18. Goshen R., Ariel I., Shuster S., Hochberg A., Vlodavsky I., de Groot N., et al. Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis. Mol Hum Reprod 2 9 (1996) 685-691
19. San Martin S., Soto-Suazo M., and Zorn T.M. Distribution of versican and hyaluronan in the mouse uterus during decidualization. Braz J Med Biol Res 36 8 (2003) 1067-1071
20. Blois S., Zenclussen A.C., Roux M.E., Olmos S., di Conza J., Arck P.C., et al. Asymmetric antibodies (Aab) in the female reproductive tract. J Reprod Immunol 64 1-2 (2004) 31-43
21. Garcia M.G., Tirado-Gonzalez I., Handjiski B., Tometten M., Orsal A.S., Hajos S.E., et al. High expression of survivin and down-regulation of Stat-3 characterize the feto-maternal interface in failing murine pregnancies during the implantation period. Placenta 28 7 (2007) 650-657
22. Sugahara K.N., Hirata T., Hayasaka H., Stern R., Murai T., and Miyasaka M. Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. J Biol Chem 281 9 (2006) 5861-5868
23. Jameson J.M., Cauvi G., Sharp L.L., Witherden D.A., and Havran W.L. Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J Exp Med 201 8 (2005) 1269-1279
24. Mummert M.E., Mummert D., Edelbaum D., Hui F., Matsue H., and Takashima A. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J Immunol 169 8 (2002) 4322-4331
25. Stern M., and Stern R. An ELISA-like assay for hyaluronidase and hyaluronidase inhibitors. Matrix 12 5 (1992) 397-403
26. Raio L., Cromi A., Ghezzi F., Passi A., Karousou E., Viola M., et al. Hyaluronan content of Wharton's jelly in healthy and down syndrome fetuses. Matrix Biol 24 2 (2005) 166-174
27. Calabro A., Benavides M., Tammi M., Hascall V.C., and Midura R.J. Microanalysis of enzyme digests of hyaluronan and chondroitin/dermatan sulfate by fluorophore-assisted carbohydrate electrophoresis (FACE). Glycobiology 10 3 (2000) 273-281
28. Karousou E.G., Militsopoulou M., Porta G., De Luca G., Hascall V.C., and Passi A. Polyacrylamide gel electrophoresis of fluorophore-labeled hyaluronan and chondroitin sulfate disaccharides: application to the analysis in cells and tissues. Electrophoresis 25 17 (2004) 2919-2925
29. Uchiyama T., Sakuta T., and Kanayama T. Regulation of hyaluronan synthases in mouse uterine cervix. Biochem Biophys Res Commun 327 3 (2005) 927-932
30. Salamonsen L.A., Shuster S., and Stern R. Distribution of hyaluronan in human endometrium across the menstrual cycle. Implications for implantation and menstruation. Cell Tissue Res 306 2 (2001) 335-340
31. Adamia S., Maxwell C.A., and Pilarski L.M. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord 5 (2005) 3-14
32. Itano N., Sawai T., Yoshida M., Lenas P., Yamada Y., Imagawa M., et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274 35 (1999) 25085-25092
33. Patel S., Turner P.R., Stubberfield C., Barry E., Rohlff C.R., Stamps A., et al. Hyaluronidase gene profiling and role of hyal-1 overexpression in an orthotopic model of prostate cancer. Int J Cancer 97 4 (2002) 416-424
34. Harada H., and Takahashi M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem 282 8 (2007) 5597-5607
35. Stern R. Hyaluronan metabolism: a major paradox in cancer biology. Pathol Biol 53 7 (2005) 372-382
36. Flannery C.R., Little C.B., Hughes C.E., and Caterson B. Expression and activity of articular cartilage hyaluronidases. Biochem Biophys Res Commun 251 3 (1998) 824-829
37. Lokeshvar V.B., Schroeder G.L., Carey R.I., Soloway M.S., and Iida N. Regulation of hyaluronidase activity by alternative mRNA splicing. J Biol Chem 277 37 (2002) 33654-33663
38. Fiszer-Szafarz B., Litynska A., and Zou L. Human hyaluronidases: electrophoretic multiple forms in somatic tissues and body fluids. Evidence for conserved hyaluronidase potential N-glycosylation sites in different mammalian species. J Biochem Biophys Methods 45 2 (2000) 103-116
39. Clark D.A., Coulam C.B., Daya S., and Chaouat G. Unexplained sporadic and recurrent miscarriage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum Reprod Update 7 5 (2001) 501-511
40. + cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. J Immunol 172 10 (2004) 5893-5899
41. Blois S.M., Kammerer U., Alba Soto C., Tometten M.C., Shaikly V., Barrientos G., et al. Dendritic cells: key to fetal tolerance?. Biol Reprod 77 4 (2007) 590-598
42. Kim Y.M., Romero R., Oh S.Y., Kim C.J., Kilburn B.A., Armant R., et al. Toll-like receptor 4. A potential link between "danger signals", the innate immune system, and preeclampsia?. Am J Obstet Gynecol 193 (2005) 921.e1-921.e8
43. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195 1 (2002) 99-111
44. Do Y., Nagarkatti P.S., and Nagarkatti M. Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells. J Immunother 27 1 (2004) 1-12